EPIGEN
Research Areas
At a Glance
- Status: Active Consortium
- Year Launched: 2006
- Initiating Organization: The University of Southampton (UK)
- Initiator Type: Academia
- Disease focus:
Obesity, Type 2 Diabetes - Location: International
Abstract
EPIGEN is an international, collaborative group of leading epilepsy research, formed with the goal of applying genomics to epilepsy therapeutics and predisposition. The consortium stands at the forefront of this next phase of epilepsy genetics research. EPIGEN is delivering a highly interactive and translational genetics research program incorporating patients actively seen in clinics, their clinicians, and scientists to improve knowledge of epilepsy and better the lives of those living with this condition.
Sponsors & Partners
Beaumont Hospital and the Royal College of Surgeons in Ireland |
Duke University |
Universite Libre de Bruxelles |
University College London |